Cardiovascular Market Global Partnering Deals 2010 To 2016 Deal Trends, Players And Financials
RnRMarketResearch.com adds “Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials” to its database.
Pune, India – July 6, 2016 /MarketersMedia/ —
Global Cardiovascular Market Partnering 2010 to 2016 provides the full collection of Cardiovascular disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.
• Trends in Cardiovascular partnering deals
• Financial deal terms for headline, upfront and royalty by stage of development
• Cardiovascular partnering agreement structure
• Cardiovascular partnering contract documents
• Top Cardiovascular deals by value
• Most active Cardiovascular dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right t- license a licensor’s product or technology. More often these days these deals tend t- be multi-component including both a collaborative R&D and a commercialization of outcomes element.
Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=80617
The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.
The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers t- analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Cardiovascular dealmaking trends.
Chapter 1 provides an introduction t- the report.
Chapter 2 provides an overview of the trends in Cardiovascular dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Cardiovascular deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Cardiovascular dealmakers, together with a full listing of deals t- which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access t- the contract.
Chapter 5 provides comprehensive access t- Cardiovascular deals since 2010 where a deal contract is available, providing the user with direct access t- contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink t- an online version of the deal record contract document, providing easy access t- each contract document on demand.
Chapter 6 provides a comprehensive directory of all Cardiovascular partnering deals by specific Cardiovascular target announced since 2010. The chapter is organized by specific Cardiovascular therapeutic target. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.
Complete research report of 1000 pages with TOC is available at http://www.rnrmarketresearch.com/cardiovascular-partnering-terms-and-agreements-market-report.html
Report scope
Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to cardiovascular trends and structure of deals entered into by leading companies worldwide.
• Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials includes:
• Trends in cardiovascular dealmaking in the biopharma industry since 2010
• Analysis of cardiovascular deal structure
• Access to headline, upfront, milestone and royalty data
• Access to over 1,000 cardiovascular deal records
• The leading cardiovascular deals by value since 2010
• In Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials, the available deals are listed by:
• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
For more information, please visit http://www.rnrmarketresearch.com/
Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41
Release ID: 122215
Copyright © 1999-2013 SproutNews.com
